Pair Name | Epigallocatechin gallate, Doxorubicin | ||
Phytochemical Name | Epigallocatechin gallate (PubChem CID: 65064 ) | ||
Anticancer drug Name | Doxorubicin (PubChem CID: 31703 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Drug Name | Doxorubicin |
Adverse Reactions | Nausea, vomiting, diarrhoea. This was inferred cold nature anticancer drug. |
Recommendations | Hot: Ligusticum chuam; Angelica sinensis; Zingiber officinale; Panax ginseng; Pogostemon cablin |
Reference | ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899. ref_link |
Pair Name | Epigallocatechin gallate, Doxorubicin | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Induction-->Immunogenic cell death | |||
Gene Regulation | Down-regulation | Expression | ABCB1 | hsa5243 |
In Vitro Model | MCF-7 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_0031 |
NCI-ADR-RES | High grade ovarian serous adenocarcinoma | Homo sapiens (Human) | CVCL_1452 | |
In Vivo Model | About 1.0×10⁶ MCF-7/ADR cells were slowly injected into the subcutaneous region of male nude mice. | |||
Result | PEI-DOX/EGCG/FA can inhibit the expression of P-gp and reverse the MDR in tumor cells. It also shows the ability of remove oxygen free radicals effectively to prevent the cardiotoxicity of DOX. |
Pair Name | Epigallocatechin gallate, Doxorubicin | |||
Disease Info | [ICD-11: 2B51] | Osteosarcoma | Investigative | |
Biological Phenomena | Induction-->Autophagy | |||
Gene Regulation | Down-regulation | Activity | DLL3 | hsa10683 |
Down-regulation | Activity | NOTCH3 | hsa4854 | |
Down-regulation | Expression | SOX2-OT | KEGG ID N.A. | |
In Vitro Model | U2OS | Osteosarcoma | Homo sapiens (Human) | CVCL_0042 |
SaOS-2 | Osteosarcoma | Homo sapiens (Human) | CVCL_0548 | |
In Vivo Model | 1×10⁵ indicated cells were inoculated subcutaneously into the inguinal folds of NOD/SCID mice. | |||
Result | SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition |
Pair Name | Epigallocatechin gallate, Doxorubicin | |||
Disease Info | [ICD-11: 2B66.Z] | Oral cancer | Investigative | |
Biological Phenomena | Induction-->Oxidative Stress | |||
Gene Regulation | Up-regulation | Expression | ROS1 | hsa6098 |
In Vitro Model | KB-A1 | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_1D82 |
Result | These results demonstrate that the reversal effect of TP and EGCG on MDR acts, at least in part, regulating the doxorubicin induced intracellular concentration of ROS. |
No. | Title | Href |
---|---|---|
1 | Enhanced therapeutic efficacy of doxorubicin against multidrug-resistant breast cancer with reduced cardiotoxicity. Drug Deliv. 2023 Dec;30(1):2189118. doi: 10.1080/10717544.2023.2189118. | Click |
2 | SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition. J Exp Clin Cancer Res. 2018 Feb 23;37(1):37. doi: 10.1186/s13046-018-0689-3. | Click |
3 | Reversal of multidrug resistance in KB cells with tea polyphenol antioxidant capacity. Cancer Biol Ther. 2005;4(4):468-473. doi:10.4161/cbt.4.4.1698 | Click |